EUA
Amplitude Solution with the TaqPath COVID-19 High-Throughput Combo Kit
FDA Emergency Use Authorization · Thermo Fisher Scientific Inc. · Nov 4, 2022
Key facts
| Product | Amplitude Solution with the TaqPath COVID-19 High-Throughput Combo Kit |
|---|---|
| Company | Thermo Fisher Scientific Inc. |
| Product type | Real-time RT-PCR, Saliva, Multiple Targets |
| Date | Nov 4, 2022 |
| FDA page | fda.gov |
At a glance
- 1–9 Authorization documents
- 1–9 EUAs for this company
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Emergency Use Authorizations
Emergency Use Authorizations allow the FDA to permit unapproved medical products, or unapproved uses of approved products, during a declared public health emergency.
Source: U.S. Food and Drug Administration (FDA), Emergency Use Authorizations · Source date: